LONDON, July 27 (Reuters) - GlaxoSmithKline plans275 million pounds ($361 million) of new investments at threedrug manufacturing sites in Britain, signalling its confidencein the country despite last month's vote to leave the EuropeanUnion. (Reporting by Ben Hirschler; Editing by David Holmes)
LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
Read more